Health
Monoclonal Antibody Combo Treatment Reduces Viral Load in COVID – Medscape
Bamlanivimab and etesevimab together were associated with a statistically significant reduction in SARS-CoV-2. Bamlanivimab alone, however, showed no significant…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A combination treatment of neutralizing monoclonal antibodies bamlanivimab and etesevimab was associated with a statistically significant reduction in SARS-CoV-2 at day 11 compared with placebo among nonhospitalized patients who had mild-to-moderate COVID-19, new data indicate.
However, bamlanivimab alone in three different single-infusion doses showed no significant reduction in viral load compared…
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoRainbow Beach surfer’s untold 7/7 story
-
General24 hours agoIndigenous excellence honoured in NAIDOC’s 50th year
-
Noosa News12 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba